#HepatitisDelta
📢 AASLD's second Expert-Based Practice Opinion (EXPO) is here!

Published in #HEPATOLOGY, the latest EXPO provides timely, practical guidance on screening, diagnosis, monitoring and treatment of #HepatitisDelta (HDV).

🔗 Read more: https://bit.ly/4iDT2Oz
November 6, 2026 at 3:37 PM
Neglect of #HDV #HepatitisDelta in #clinicaltrials described in a poster - especially important as #bulevirtide arrives on the scene, but access and insights limited by inequity and data gaps. This work led by @mariondelphin.bsky.social
March 22, 2025 at 8:25 PM
Neglect of #HDV #HepatitisDelta in #clinicaltrials described in a poster - especially important as #bulevirtide arrives on the scene, but access and insights are limited by inequity and data gaps.
This work led by @mariondelphin.bsky.social
March 22, 2025 at 8:12 PM
BREAKING: FDA approves Hepcludex, the first-ever treatment for chronic hepatitis delta virus infection in adults. This milestone addresses a critical u…

#FDAapproval #Hepatitisdelta #Hepcludex #Liverdisease #Viralhepatitis

#FDAapproval #Hepatitisdelta #Hepcludex #Liverdisease #Viralhepatitis

h…
FDA Approves First Hepatitis Delta Treatment
BREAKING: FDA approves Hepcludex, the first-ever treatment for chronic hepatitis delta virus infection in adults. This milestone addresses a critical u… #FDAapproval #Hepatitisdelta #Hepcludex #Liverdisease #Viralhepatitis
news.gmj.ge
June 16, 2026 at 8:25 AM
📢 The 27th Hepatitis Delta International Network Meeting takes place May 7, 2025, during #EASL2025 in Amsterdam!
A closed expert event on the latest in #HepatitisDelta research.
🔬 Scientists & healthcare professionals
🔗 www.dzif.de/en/event/27t...
27th HDIN Meeting (Hepatitis Delta International Network) | German Center for Infection ResearchMenüMenüSucheSucheE-Mail
27th HDIN Meeting
www.dzif.de
May 6, 2025 at 7:28 AM